Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
UCB SA (UCBJY)
OTHER OTC:UCBJY
Holding UCBJY?
Track your performance easily
UCBJY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$34.86 - $78.66
Previous Close$78.47
Volume7.30K
Average Volume (3M)20.73K
Market Cap
$29.64B
Enterprise Value$31.55B
Total Cash (Recent Filing)€1.14B
Total Debt (Recent Filing)€2.90B
Price to Earnings (P/E)80.3
Beta0.39
Next Earnings
Jul 25, 2024Last Dividend Ex-Date
Apr 26, 2024Dividend Yield0.58%
Share Statistics
EPS (TTM)0.98
Shares Outstanding379,189,796
10 Day Avg. Volume15,459
30 Day Avg. Volume20,735
Standard Deviation0.09
R-Squared0.22
Alpha0.00510
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
UCB SA News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
UCBJY FAQ
What was UCB SA’s price range in the past 12 months?
UCB SA lowest stock price was $34.85 and its highest was $78.66 in the past 12 months.
What is UCB SA’s market cap?
Currently, no data Available
When is UCB SA’s upcoming earnings report date?
UCB SA’s upcoming earnings report date is Jul 25, 2024 which is 45 days ago.
How were UCB SA’s earnings last quarter?
UCB SA released its earnings results on Feb 28, 2024. The company reported $0.845 earnings per share for the quarter, beating the consensus estimate of $0.119 by $0.726.
Is UCB SA overvalued?
According to Wall Street analysts UCB SA’s price is currently Overvalued.
Does UCB SA pay dividends?
UCB SA pays a Annually dividend of $0.46 which represents an annual dividend yield of 0.58%. See more information on UCB SA dividends here
What is UCB SA’s EPS estimate?
UCB SA’s EPS estimate is $1.
How many shares outstanding does UCB SA have?
UCB SA has 389,012,000 shares outstanding.
What happened to UCB SA’s price movement after its last earnings report?
UCB SA reported an EPS of $0.845 in its last earnings report, beating expectations of $0.119. Following the earnings report the stock price went up 7.95%.
Which hedge fund is a major shareholder of UCB SA?
Currently, no hedge funds are holding shares in UCBJY
---
UCB SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.04%
12-Months-Change
Fundamentals
Return on Equity
3.78%
Trailing 12-Months
Asset Growth
1.36%
Trailing 12-Months
Company Description
UCB SA
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, both of which have lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Evenity (osteoporosis), and Nayzilam (cluster seizures).
---
UCBJY Company Deck
---
UCBJY Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---